Jefferies lowered estimates and its price target on Auxilium Pharmaceuticals (NASDAQ: AUXL) from $29 to $25 following Q1 results but ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE